Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Autoimmune Diseases × remdesivir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Syncytial Virus Infections 1 Autoimmune Diseases 1

Interventions

Prednisone 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Immunoglobulins, Intravenous 1 Etoposide 1 Cytarabine 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Fred Hutchinson Cancer Center

Phase 2 Recruiting

Autoimmune Diseases, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡